Core Viewpoint - The third China International Supply Chain Promotion Expo showcases the innovative achievements of Furuida, a subsidiary of Lushang Group, focusing on the integration of traditional Chinese medicine and synthetic biology in the beauty and health industry [1] Group 1: Product Innovation - Furuida presented a full-chain innovation from traditional Chinese medicine extraction to end products, highlighting the "green journey" of ingredients like Centella Asiatica to anti-aging serums [3] - The company integrates traditional Chinese medicine with artificial intelligence for precise control in the production of sensitive skin series products, exemplifying a new paradigm of "green intelligent manufacturing" [3] - The MatrixColla-1 product utilizes a precise ratio of type III recombinant collagen, elastin, and fibronectin to simulate the extracellular matrix structure of the dermis, providing comprehensive anti-aging benefits [4] Group 2: Sustainable Practices - Furuida's green supply chain initiatives include biodegradable packaging that reduces degradation time by 60%, with traditional PE bottles taking 450 years to decompose compared to 180 days for plant-based packaging [5] - The company’s raw materials, such as dihydroxyphenethyl alcohol and sodium hyaluronate, are certified by EU ECOCERT, and their bio-fermentation process reduces emissions by 35% compared to traditional chemical methods [5] Group 3: Research and Development Ecosystem - The innovation ecosystem of Lushang Group combines research institutes, corporate R&D centers, and industrial bases, enhancing the transformation of scientific research into products [7] - Furuida has led or participated in the formulation of over 80 national and industry standards and holds 434 valid patents, including 189 invention patents [7] - The company aims to continue promoting sustainable "Chinese solutions" in the global market, leveraging modernization of traditional Chinese medicine and synthetic biology [7]

证券代码：600223 证券简称：福瑞达 公告编号：2025-020 鲁商福瑞达医药股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.06元 相关日期 本次利润分配方案经公司2025 年 6 月 25 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本1,016,568,775股为基数，每股派发现金红利 0.06元（含税），共计派发现金红利60,994,126.50元。 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/7/23 | － | 2025/7/24 | 2025/7/24 | 三、 相关日期 1. ...

Core Viewpoint - The third China International Supply Chain Promotion Expo showcases the innovative practices of Shandong Lushang Group, emphasizing a new supply chain model that integrates product co-research, channel collaboration, ecological construction, and financial empowerment [1][3]. Group 1: Supply Chain Innovations - Lushang Group utilizes a "one plate of goods" approach to overcome traditional resource fragmentation and channel disconnection, forming a supply chain platform that integrates various internal and external resources [3]. - The company will present its supply chain highlights at the expo, including products from its subsidiary, Furuida, which features advanced technologies and sustainable practices in the beauty industry [3][4]. - Furuida's star products, such as the hyaluronic acid series and patented collagen technology, will be showcased, demonstrating significant advancements in product efficacy and sustainability [3][4]. Group 2: Collaboration and Product Development - The Shandong Pharmaceutical Institute, a key player in Lushang Group's healthcare sector, recently won a provincial science and technology award for its innovative drug delivery technology, enhancing product efficacy and stability [4]. - Lushang Group's retail arm, Yinzou Group, is focused on deepening partnerships with manufacturers to streamline the supply chain and create a unique commercial ecosystem [4]. - The expo will feature products from various regions in Shandong, highlighting local specialties and Lushang's own brand offerings, thereby reconstructing an efficient demand-production-consumption chain [4]. Group 3: Strategic Initiatives - Yitong Jinfu Supply Chain is implementing the national "dual circulation" strategy by assisting companies like Weifang Sheng'an Food Co., Ltd. in transitioning from export to domestic sales [5]. - The Shandong Innovation Research Institute will showcase self-developed products under its brands, emphasizing high-quality offerings in the tea market [5]. - Lushang Group's wine division, Chateau de Cugat, ensures quality control from grape cultivation to consumer delivery, enhancing the supply chain's transparency and efficiency [6]. Group 4: Agricultural Practices - Lushang's agricultural operations focus on full-chain control from seed to shelf, utilizing standardized planting and traceable farming practices to ensure product quality [6]. - The company employs advanced techniques to maintain the nutritional integrity of its products, showcasing a commitment to sustainable agricultural practices [6]. Group 5: Overall Impact - The expo serves as a platform for Lushang Group to demonstrate its comprehensive supply chain innovations and achievements, with a focus on collaboration and sustainability [6].

Core Insights - The article highlights the impressive display of Furuida, a subsidiary of Lushang Group, at the third Chain Expo, showcasing its innovations in the beauty and health sectors, particularly in traditional Chinese medicine modernization and synthetic biology breakthroughs [1][10] - Furuida's achievements reflect Lushang Group's strategic focus on technological innovation and collaboration with research institutions like the Shandong Academy of Pharmaceutical Sciences [1][9] Product Matrix: Breakthroughs from Raw Materials to End Solutions - Furuida's exhibition presented a comprehensive range of products, integrating traditional Chinese medicine with modern technology, particularly addressing sensitive skin issues through advanced extraction techniques [5] - The company has made significant advancements in synthetic biology, particularly with its royal jelly acid series, which targets aging skin by utilizing engineered bacteria for efficient production [5] Green and Sustainable Practices - Furuida emphasizes sustainability throughout its supply chain, producing raw materials that meet international certification standards and utilizing biodegradable packaging that reduces degradation time by over 60% compared to traditional plastics [6] End Products and Light Medical Aesthetic Solutions - The company offers a wide array of products, including the Yilian hyaluronic acid series and the Ai'er Doctor micro-ecological skincare line, which have gained popularity and recognition for their innovative approaches to skin health [7] R&D Core: From Laboratory to Market - Furuida has established a robust R&D system that spans basic research to industrial application, particularly excelling in the field of hyaluronic acid with patented technologies that enhance its market competitiveness [8] Lushang Innovation Ecosystem: From Single Point Breakthroughs to Systemic Empowerment - Furuida's innovations are part of Lushang Group's broader strategy to integrate research and development with industry, supported by the Shandong Academy of Pharmaceutical Sciences, which has made significant contributions to the company's technological advancements [9] Conclusion: Advancing China's Global Influence in Manufacturing - Furuida's success at the Chain Expo and its global supply chain strategies illustrate the upgrading path of China's beauty and health industry, driven by technological innovation and sustainable practices [10]

Core Viewpoint - The article highlights the advancements in smart factories in Shandong Province, particularly focusing on the achievements of Shandong Furuida Biological Co., Ltd. and its intelligent manufacturing capabilities, which have led to significant improvements in efficiency and cost reduction [1][3]. Group 1: Smart Factory Achievements - Shandong Furuida Biological's intelligent factory has reduced the workforce on a single mask production line from 60 to just 7 workers, demonstrating a shift from labor-intensive to automated processes [2][5]. - The production capacity of Furuida has expanded from 15 million pieces annually to 250 million pieces, showcasing the effectiveness of automation in scaling production without a proportional increase in labor [2][5]. - The intelligent factory's implementation of a Manufacturing Execution System (MES) has improved production efficiency by 16% and reduced production costs by over 8% compared to 2023 [5][6]. Group 2: Industry Trends and Challenges - The article notes that many companies face a contradiction between the need for large-scale production and the demand for personalized products, which smart factories are addressing through automation and data management [1][3]. - Furuida's approach to managing different product specifications on the same production line highlights the challenges of maintaining efficiency while catering to diverse consumer preferences in the cosmetics industry [9][10]. - The intelligent manufacturing model allows for precise tracking and management of products throughout the supply chain, enhancing quality control and brand integrity [10][11]. Group 3: Economic Impact - The construction of smart factories, such as Furuida's, is seen as a significant investment with a high return, as it leads to substantial operational cost savings and improved production efficiency [3][6]. - The intelligent factory at Jicheng Electronics has also reported a 30% reduction in construction time and a 25% increase in space utilization, further emphasizing the economic benefits of smart manufacturing [6][7]. - Overall, the shift towards smart factories is expected to provide a replicable model for other companies in the industry, promoting broader adoption of digital transformation strategies [6][11].

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [5][31]. Core Insights - The June CPI has turned from decline to increase, with a year-on-year rise of 0.1%, marking the end of four consecutive months of decline. Core CPI also rose by 0.7%, the highest increase in nearly 14 months [3][22]. - The report highlights significant events in the beauty care sector, including the ranking of brands on Tmall and the entry of certain brands into new sales channels [3][23]. - The travel sector shows a recovery with a 5.7% week-on-week increase in flight operations, and a year-on-year increase of 4.1% compared to 2024 [4][28]. Market Performance - For the week of July 7-11, 2025, the retail trade, social services, and beauty care sectors saw increases of +2.20%, +2.11%, and +1.52% respectively, ranking 11th, 13th, and 20th among 31 primary industries [14][19]. - The internet e-commerce, trade, and professional services sub-sectors performed particularly well, with increases of +4.37%, +4.36%, and +4.14% respectively [16][19]. Key Industry Data and News - The report notes that the beauty care category on Tmall saw a shift in brand rankings, with local brands' market share decreasing slightly [23]. - The government has introduced policies to stabilize employment and support market expectations, which are expected to drive economic growth [3][22]. Company Announcements - Guilin Tourism expects a significant profit increase of 142% year-on-year for H1 2025, while Chongqing Department Store reported a net profit increase of 8.74% [29][30]. - Companies like Guibao Pet are investing in smart warehousing to enhance operational efficiency [30]. Investment Recommendations - The report recommends focusing on companies such as Shangmei Co., Juzhibio, Marubi, Runben, Proya, Chaohongji, Blukoo, and Furuida within the beauty care and new consumption sectors [5][31].

Core Insights - The hair care market is experiencing rapid growth, with a projected market size of 899.95 billion yuan in 2024, reflecting a year-on-year increase of 59.32% [2][3] - In the first half of 2025, at least 33 brands launched 54 new products, focusing on specific functionalities such as scalp and hair repair [3][4] Product Trends - The emphasis on scalp care and hair repair is a significant trend, with over half of the new products highlighting these functionalities [3][4] - Multi-functional products are gaining traction, with brands combining various benefits such as anti-dandruff, oil control, and hair strengthening [8][10] Unique Ingredients and Technologies - Brands are increasingly using proprietary and specialized ingredients to differentiate their products, with 14 out of 54 new products featuring multiple plant extracts [11][12] - The trend of incorporating skincare ingredients into hair care products is becoming more prevalent, enhancing the effectiveness of hair care solutions [11][12] Market Dynamics - The hair care market is expected to continue its upward trajectory, with projections indicating it will reach 827.9 billion yuan by 2027 [15] - Numerous cosmetic companies are entering the hair care sector, aiming to capture a share of this growing market [15][16] Competitive Landscape - The majority of new products are positioned in the affordable or mid-range market, while the high-end segment remains dominated by foreign brands [18][19] - Companies are focusing on precise positioning and robust R&D capabilities to establish a competitive edge in a crowded market [19]

Investment Rating - The report maintains a positive outlook on the cosmetics and medical beauty industry, indicating a "Buy" recommendation for several companies within the sector [2][14]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Beauty Care Index rising by 1.5% from July 4 to July 11, 2025, which is below the market average [3][5]. - The introduction of new products in the regenerative medicine sector, particularly in the "童颜针" (youthful needle) category, is expected to enhance consumer interest and expand the market [2][8]. - The report highlights strong anticipated earnings growth for several key companies in the cosmetics sector for the second quarter of 2025, with notable increases in revenue and net profit for brands like 上美股份 (Shangmei), 丸美股份 (Marubi), and 珀莱雅 (Proya) [9][10][11]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market, with specific indices showing varied performance, such as the Shenwan Cosmetics Index increasing by 2.6% [3][5]. - The report notes that the demand for cosmetics is recovering, with a 4.1% year-on-year increase in retail sales for the first five months of 2025 [19][20]. Company Performance - 上美股份 (Shangmei) is expected to see a revenue increase of 16% and a net profit increase of 25% in the first half of 2025 [10]. - 丸美股份 (Marubi) anticipates a 22% revenue growth and a 28% increase in net profit for the second quarter of 2025 [10]. - 珀莱雅 (Proya) is projected to achieve a 10% revenue growth and a 15% increase in net profit for the second quarter of 2025 [10]. - 毛戈平 (Mao Geping) expects a significant revenue increase of 38% and a net profit increase of 35% in the first half of 2025 [10]. - 若羽臣 (Ruoyuchen) forecasts a remarkable 70% revenue growth and a 75% increase in net profit for the second quarter of 2025 [10]. Market Trends - The report emphasizes the ongoing trend of domestic brands gaining market share, with national brands occupying five of the top ten positions in the skincare market [32]. - The regenerative medicine sector is expanding, with new products enhancing consumer engagement and market growth potential [2][8]. Investment Recommendations - The report recommends focusing on companies with strong brand matrices and high growth potential, such as 上美股份 (Shangmei), 珀莱雅 (Proya), and 丸美股份 (Marubi) [14]. - It suggests monitoring companies that leverage e-commerce and social media platforms effectively, such as 若羽臣 (Ruoyuchen) and 毛戈平 (Mao Geping) [14].

Core Insights - The skincare industry is experiencing intense competition in technology, with numerous suppliers showcasing unique ingredients and certifications at a recent cosmetics trade show [1][2][3] - The trend of emphasizing active ingredients and technical claims on product packaging is prevalent, as brands seek to carve out market positions by replicating successful commercial models [4][5] - The lack of authoritative industry standards and clarity on ingredient efficacy is causing confusion and skepticism among consumers [6][7][8] Group 1: Active Ingredients and Technology Trends - Active proteins and plant extracts remain core competitive areas in the skincare industry, with leading brands continuing to invest heavily in research and development [10][11] - The popularity of active proteins is driven by their previous applications in medical and aesthetic fields, which lend credibility to their use in consumer products [15][20] - New technologies in plant extraction are emerging, aiming to address traditional challenges such as stability and absorption rates [18][19] Group 2: Marketing and Industry Challenges - The rapid iteration of core ingredients in domestic beauty brands has outpaced normal industry evolution, leading to communication gaps between technology, products, and consumers [22][23] - The absence of unified national standards for new ingredients has resulted in market confusion and potential harm to consumers [24][26] - Overemphasis on marketing claims has led to exaggerated efficacy narratives, causing consumer dissatisfaction and adverse reactions [30][31][33] Group 3: Future Directions and Brand Strategies - The skincare industry is entering a period of deep adjustment, with competition shifting from ingredient-based to ecosystem-building capabilities [37][39] - Brands must find new competitive advantages beyond ingredient efficacy, such as emotional value and consumer experience [41][42] - The rise of niche markets, including male skincare and elderly care, presents new opportunities for growth and diversification [48][49]

Core Insights - The demand for high-quality "good houses" is strong among homebuyers in Harbin, indicating a shift in market preferences towards better living conditions and amenities [3][16]. Market Performance - On June 22, over 900 groups of customers attended the opening of the Lushang Longyuefu project, resulting in more than 500 units sold, totaling nearly 800 million yuan, setting a new record for the Harbin real estate market [3]. - The first half of 2025 saw significant sales in high-quality improvement housing projects, with some projects achieving full sales within 10 months and others selling around 100 units per month [7][16]. Buyer Preferences - Homebuyers are increasingly prioritizing factors such as planning, layout, and amenities over price, showing a willingness to pay more for quality improvements [3][8]. - The trend indicates a growing preference for larger units, with three-bedroom, two-bathroom layouts being particularly sought after [10]. Sales Trends - The sales performance of various projects, such as the Huolong Chenyue No. 1 and Kunlun Fu, has been strong, with significant sales figures reported in the first half of the year [7][16]. - The second-hand housing market in Harbin also exceeded expectations, with a year-on-year increase in transactions and a notable rise in the proportion of improvement buyers [14]. Future Developments - Several high-quality projects are set to launch in the second half of 2025, focusing on meeting the "good house" standards in terms of soundproofing, waterproofing, fire safety, and structural integrity [16]. - The market is transitioning from "housing for all" to "housing for quality," with an increasing proportion of larger units being sold [16].